Artivion, Inc.

Stocks

Market Closed - NYSE Other stock markets 04:00:02 2026-06-11 pm EDT			5-day change	1st Jan Change
20.60 ^USD	+0.64%		-1.15%	-54.83%

May. 18	Artivion Closes $175 Million Acquisition of Endospan	MT
May. 17	Artivion, Inc. completed the acquisition of Endospan Ltd.	CI

Published on 05/10/2026 at 03:05 pm EDT - Modified on 05/25/2026 at 05:07 pm EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good afternoon, and welcome to Artivion's Fourth Quarter and Year-End 2025 Earnings Conference Call.

[Operator

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

May. 18	Artivion Closes $175 Million Acquisition of Endospan	MT
May. 17	Artivion, Inc. completed the acquisition of Endospan Ltd.	CI
May. 10	Artivion, Inc., Q1 2026 Earnings Call, May 07, 2026
May. 07	Earnings Flash (AORT) Artivion, Inc. Reports Q1 Revenue $116.3M, vs. FactSet Est of $115.7M	MT
May. 07	Earnings Flash (AORT) Artivion, Inc. Posts Q1 Adjusted EPS $0.08 per Share, vs. FactSet Est of $0.03	MT
May. 07	Artivion, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
May. 07	Artivion, Inc. Lowers Earnings Guidance for the Full Year 2026	CI
May. 06	Artivion, Inc. has exercised option to acquire Endospan Ltd. for approximately $380 million.	CI
Apr. 07	Artivion Inc Announces U S FDA Approval of the Nexus Aortic Arch System	CI
Apr. 07	Artivion Says FDA Approves NEXUS Aortic Arch System, Secures Option to Acquire Endospan	MT
Apr. 07	Artivion announces U.S. FDA approval of the Nexus® aortic arch system	RE
Mar. 03	Artivion Insider Sold Shares Worth $566,989, According to a Recent SEC Filing	MT
Feb. 12	Artivion, Inc., Q4 2025 Earnings Call, Feb 12, 2026
Feb. 12	Artivion's Q4 Adjusted Earnings, Revenue Rise	MT
Feb. 12	Earnings Flash (AORT) Artivion, Inc. Reports Q4 Revenue $116.0M, vs. FactSet Est of $116.5M	MT